We found that methylation of RASSF1-1α (representing gene silencing) significantly correlates with low pS127-YAP1 in glioma, bladder, and breast cancer cohorts (Figure 1A), suggesting that YAP1 may be nuclear and active in RASSF1-methylated tumors. Here, RASSF1 is linked to central nervous system cancer.